Background: Cervical cancer is the second most common cancer type seen among women in most countries and an important cause of mortality. Although it is a preventable disease, most women living in developing countries cannot reach effective screening programs. It is essential that appropriate education about cervical cancer is provided.

Objective: This experimental field study was performed with the aim of evaluating the efficacy of training given to women about cervical cancer risk factors and primary and secondary prevention precautions.

Methods: The research focused on women between 25 and 29 years of age, literate, married and having social security. The study was conducted in the district of Evka 4 Health Care Center between the dates of April to August 2005. The women were given survey forms and questionnaires in order to determine their socio-demographic features and knowledge level about cervical cancer in the course of home visits. They were trained and given a manual at the data collection stage. At a second visit, carried out three months later, the trained women were again evaluated for their knowledge level about cervical cancer, risk factors and whether they had undergone a Pap smear test.

Results: Together with the difference between pre-/post-training mean information scores related to women's cervical cancer risk factors, the difference between the women's having a Pap smear test in the pre-/post-training period was found statistically significant. Only 16.3% of the women stated that they had a Pap smear test in the post-training period.

Conclusions: It was determined that the women were in need of knowledge about risk factors related to cervical cancer, prevention from and early diagnosis of cervical cancer, but there was no significant increase in the rate of having a Pap smear test despite the increase in the knowledge level with the training given.

Download full-text PDF

Source

Publication Analysis

Top Keywords

cervical cancer
36
risk factors
20
cancer risk
16
pap smear
16
knowledge level
12
smear test
12
cancer
10
cervical
9
efficacy training
8
women
8

Similar Publications

MTIOT: Identifying HPV subtypes from multiple infection data.

Comput Struct Biotechnol J

December 2024

Key Laboratory of Systems Biology, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai 200031, China.

Persistent infection with high-risk human papillomavirus (hrHPV) is a major cause of cervical cancer. The effectiveness of current HPV-DNA testing, which is crucial for early detection, is limited in several aspects, including low sensitivity, accuracy issues, and the inability to perform comprehensive hrHPV typing. To address these limitations, we introduce MTIOT (Multiple subTypes In One Time), a novel detection method that utilizes machine learning with a new multichannel integration scheme to enhance HPV-DNA analysis.

View Article and Find Full Text PDF

The most common STD that triggers cervical cancer is the human papillomavirus. More than 20 types of human papillomavirus (HPV) can induce uterine cervical cancer. Almost all women acquire genital HPV infection soon after their first intercourse, with most of them clearing the virus within 3 years.

View Article and Find Full Text PDF

Purpose: Human papillomavirus (HPV) infection is the major cause of (pre)malignant cervical lesions. We previously demonstrated that Vvax001, a replication-incompetent Semliki Forest virus (SFV) vaccine encoding HPV type 16 (HPV16) E6 and E7, induced potent anti-E6 and -E7 cytotoxic T-cell responses. Here, we investigated the clinical efficacy of Vvax001 in patients with HPV16-positive cervical intraepithelial neoplasia grade 3 (CIN3).

View Article and Find Full Text PDF

Background: Ovarian cancer is a leading cause of mortality worldwide. The third most prevalent gynecological cancer globally, following cervical and uterine cancer, and the third leading cause of cancer-related mortality among women in Sub-Saharan Africa, including Ethiopia. The time ovarian cancer patients have to wait between diagnosis and initiation of treatment are the indicators of quality in cancer care and influence patient outcomes.

View Article and Find Full Text PDF

Association of blood group types and clinico-pathological features of gynecological cancers (GCs).

BMC Cancer

January 2025

Molecular Diseases & Diagnostics Division, Infinity Biochemistry, Infinity Solutions Unlimited, Sajjad Abad, Chattabal, Srinagar, 190010, Kashmir, India.

Background: Gynecological cancers (GCs) affect the reproductive system of females, and are of multiple types depending on the affected organ most common of which are cervical, endometrial, ovarian cancers. Among different risk factors for GCs, ABO blood group system is considered as one of the pivotal contributing factors for increased susceptibility of GCs. The aim of our study was to report on the demographics of GC patients and to investigate the relationship between the ABO blood group system and the risk of acquiring GC in our population.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!